Drug Discovery Platform Using Organoids
نویسندگان
چکیده
منابع مشابه
Drug Discovery via Human-Derived Stem Cell Organoids
Patient-derived cell lines and animal models have proven invaluable for the understanding of human intestinal diseases and for drug development although both inherently comprise disadvantages and caveats. Many genetically determined intestinal diseases occur in specific tissue microenvironments that are not adequately modeled by monolayer cell culture. Likewise, animal models incompletely recap...
متن کاملDevelopment of a Millennial Drug Discovery Platform
FOR MEDCHEM RESEARCH SEMINAR Ashootosh Tripathi, PhD;[email protected] Ashootosh Tripathi, PhD;[email protected] | UNIVERSITY OF MICHIGAN Microbes to Medicine Development of a Millennial Drug Discovery Platform Ashootosh Tripathi, PhD Research Investigator Life Sciences Institute, University of Michigan, Ann Arbor, MI48109, USA If discovery of new antibiotics continues to wane while the ability o...
متن کاملEthnobotany, Ethnopharmacology and Drug Discovery
This manuscript is a review of a number of ethnobotany and ethnopharmacology texts and papers in order to arrive at current understanding and scope of ethnobotany and ethnopharmacology. It includes either a brief definition of both fields and presenting some examples on them. Also it has a glimpse on the geographical coverage of research works throughout the world, important issue of prope...
متن کاملNovel opportunities for CFTR-targeting drug development using organoids
Cystic fibrosis (CF) is caused by mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. CFTR mutations lead to production of non-functional CFTR, reduced amounts of normal functioning CFTR or misfolded CFTR with defects in trafficking or function. For decades, CF treatment has been focused on the symptoms of CF, but pharmacotherapy using small molecules that target t...
متن کاملHepatic organoids for microfluidic drug screening.
We introduce the microfluidic organoids for drug screening (MODS) platform, a digital microfluidic system that is capable of generating arrays of individually addressable, free-floating, three-dimensional hydrogel-based microtissues (or 'organoids'). Here, we focused on liver organoids, driven by the need for early-stage screening methods for hepatotoxicity that enable a "fail early, fail cheap...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of digestive cancer reports
سال: 2022
ISSN: ['2288-1581']
DOI: https://doi.org/10.52927/jdcr.2022.10.2.82